Search research articles
Contact Us
Filters
Showing results (81-90 of 502) with videos related to
Page
of 51
Sort By:
Journal of Personalized Medicine
|
January 22, 2024
Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder
Richard E Frye, Patrick J McCarty, Brianna A Werner, et al.
Medicine and Science in Sports and Exercise
|
November 15, 2022
Load Carriage and Physical Exertion Influence Soldier Emotional Responses
Grace E Giles, Kell Grandjean DA Costa, Sara A Olenich, et al.
Journal of the American College of Cardiology
|
November 14, 2015
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib
Stephen J Nicholls, Giacomo Ruotolo, H Bryan Brewer, et al.
Journal of Lipids
|
December 6, 2014
Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
Herman J Kempen, Dorota B Schranz, Bela F Asztalos, et al.
Journal of the American Heart Association
|
August 18, 2020
Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial
Oluremi N Ajala, Olga V Demler, Yanyan Liu, et al.
Journal of Personalized Medicine
|
December 23, 2022
The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment
Richard E Frye, Alison Lane, Ashley Worner, et al.
Journal of Medicinal Chemistry
|
January 23, 2004
Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating properties
Hassan Elokdah, Theodore S Sulkowski, Magid Abou-Gharbia, et al.
Journal of Clinical Lipidology
|
September 29, 2016
Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses
Julian C van Capelleveen, John J P Kastelein, Aeilko H Zwinderman, et al.
Circulation Research
|
December 3, 2015
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study
Robert D Shamburek, Rebecca Bakker-Arkema, Alexandra M Shamburek, et al.
JACC. Basic to Translational Science
|
April 30, 2025
Apolipoprotein A1 (CSL112) Increases Lecithin-Cholesterol Acyltransferase Levels in HDL Particles and Promotes Reverse Cholesterol Transport
Rommel A Mathias, Elena Velkoska, Svetlana A Didichenko, et al.
Page
of 51
Search research articles
Search
Showing results (81-90 of 502) with videos related to
Sort By:
Page
of 51
Journal of Personalized Medicine
|
January 22, 2024
Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder
Richard E Frye, Patrick J McCarty, Brianna A Werner, et al.
Medicine and Science in Sports and Exercise
|
November 15, 2022
Load Carriage and Physical Exertion Influence Soldier Emotional Responses
Grace E Giles, Kell Grandjean DA Costa, Sara A Olenich, et al.
Journal of the American College of Cardiology
|
November 14, 2015
Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib
Stephen J Nicholls, Giacomo Ruotolo, H Bryan Brewer, et al.
Journal of Lipids
|
December 6, 2014
Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size
Herman J Kempen, Dorota B Schranz, Bela F Asztalos, et al.
Journal of the American Heart Association
|
August 18, 2020
Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial
Oluremi N Ajala, Olga V Demler, Yanyan Liu, et al.
Journal of Personalized Medicine
|
December 23, 2022
The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment
Richard E Frye, Alison Lane, Ashley Worner, et al.
Journal of Medicinal Chemistry
|
January 23, 2004
Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating properties
Hassan Elokdah, Theodore S Sulkowski, Magid Abou-Gharbia, et al.
Journal of Clinical Lipidology
|
September 29, 2016
Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses
Julian C van Capelleveen, John J P Kastelein, Aeilko H Zwinderman, et al.
Circulation Research
|
December 3, 2015
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study
Robert D Shamburek, Rebecca Bakker-Arkema, Alexandra M Shamburek, et al.
JACC. Basic to Translational Science
|
April 30, 2025
Apolipoprotein A1 (CSL112) Increases Lecithin-Cholesterol Acyltransferase Levels in HDL Particles and Promotes Reverse Cholesterol Transport
Rommel A Mathias, Elena Velkoska, Svetlana A Didichenko, et al.
Page
of 51